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Editors: Anton N. Sidawy and Bruce A. PerlerAneurysmal iliac arteries do not portend future iliac aneurysmal
enlargement after endovascular aneurysm repair for abdominal aortic
aneurysm
Melissa L. Kirkwood, Alan Saunders, Benjamin M. Jackson, Grace J. Wang,
Ronald M. Fairman, Edward Y. Woo
Objectives: The purpose of this study was to examine the fate of aneu-
rysmal iliac arteries managed during endovascular aneurysm repair (EVAR)
for abdominal aortic aneurysm (AAA).
Methods: We analyzed data from the Cook Zenith trial. Follow-up was at 1
month, 6 months, 12 months, and then annually for 5 years. Patients were
evaluated according to the largest iliac artery diameter: group A (20
mm) and group B (<20 mm). These groups were further subdivided based
on iliac artery growth 5 mm during follow-up. The Fisher exact test and
c2 test were used.
Results:: Of 736 patients treated, 671 had a follow-up examination (group A
= 274). In group A, 220 (80%) were treated with flared limbs in the common
iliac artery. Group A did not demonstrate increased iliac growth as compared
to group B. Furthermore, both groups had a similar percentage of patients
that experienced iliac artery expansion of 32.1% and 31.5%, respectively.
Extension to the external iliac artery did not affect growth (P = .4). No
difference was noted in the need for secondary interventions between
groups. However, group A patients that did not experience growth were
more likely to develop a distal type I endoleak than group B patients who
did not develop growth (P = .03). There was no difference in serious adverse
events (SAEs) between groups (P = .51). However, patients that developed
iliac artery growth in either group were less likely to have an SAE compared
to patients who did not experience growth (P = .035). There was no differ-
ence in the mean percent oversizing of the iliac limbs between groups A
and B. However, the mean percent oversizing in groups A and B that had iliac
artery growth was significantly higher than in those that demonstrated no
growth (P < .01).
Conclusion: Aneurysmal iliac arteries managed by flared limbs or external
iliac extensions at the time of EVAR for AAA do not demonstrate future iliac
growth, increased rate of secondary interventions, or SAEs compared to
patients with normal iliac arteries. This suggests that aneurysmal iliac
arteries can be safely treated with appropriately sized limbs landed in the
common or external iliac artery.Long-term results of Talent endografts for endovascular abdominal aortic
aneurysm repair
Bart A.N. Verhoeven, Evert J. Waasdorp, Madhu L. Gorrepati, Joost A. van
Herwaarden, Jan Albert Vos, Jan Wille, Frans L. Moll, Christopher K.
Zarins, Jean Paul P.M. de Vries
Background: Since the introduction of endovascular aneurysm repair
(EVAR), long-term follow-up studies reporting single-device results are* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(10)00772-0scarce. In this study, we focus on EVAR repair with the Talent stent graft
(Medtronic, Santa Rosa, Calif).
Methods: Between July 2000 and December 2007, 365 patients underwent
elective EVAR with a Talent device. Patient data were gathered prospec-
tively and evaluated retrospectively. By American Society of Anesthesiolo-
gists category, 74% were categories III and IV. Postoperative computed
tomography (CT) scanning was performed before discharge, at 3, 12 months,
and yearly thereafter. Data are presented according to reporting standards
for EVAR.
Results: The mean proximal aortic neck diameter was 27 mm (range, 16-36
mm), with a neck length <15 mm in 31% (data available for 193 patients).
Deployment of endografts was successful in 361 of 365 patients (99%).
Initially, conversion to laparotomy was necessary in four patients. Primary
technical success determined by results from computed tomography (CT)
scans before discharge was achieved in 333 patients (91%). Proximal type I
endoleaks were present in 28 patients (8%) during follow-up, and 14 of these
patients needed additional treatment for type I endoleak. The 30-day
mortality for the whole Talent group was 1.1% (4 of 365). Follow-up to 84
months is reported for 24 patients. During follow-up, 122 (33%) patients
died; in nine, death was abdominal aortic aneurysm (AAA)-related (including
30-day mortality). Kaplan-Meier estimates revealed primary clinical success
rates of 98% at 1 year, 93% at 2 years, 88% at 3 years, 79% at 4 years, 64% at 5
years, 51% at 6 years, and 48% at 7 years. Secondary interventions were per-
formed in 73 of 365 patients (20%). Ten conversions for failed endografts
were performed. Life-table yearly risk for AAA-related reintervention was
6%, yearly risk for conversion to open repair was 1.1%, yearly risk for total
mortality was 8.9%, and yearly risk for AAA-related mortality was 0.8%.
Conclusion:: Initially, technical success of endovascular aneurysm repair
(EVAR) using the Talent endograft is high, with acceptable yearly risk for
AAA-related mortality and conversion. However, a substantial amount of
mainly endovascular reinterventions is necessary during long-term follow-
up to achieve these results.National trends in utilization and postprocedure outcomes for carotid
artery revascularization 2005 to 2007
Mohammad H. Eslami, James T. McPhee, Jessica P. Simons, Andres Schanzer,
Louis M. Messina
Objective: This study compared, at a national level, trends in utilization,
mortality, and stroke after carotid angioplasty and stenting (CAS) and
carotid endarterectomy (CEA) from 2005 to 2007.
Methods: The Nationwide Inpatient Sample (NIS) was queried for patient
discharges with International Classification of Disease, Ninth Revision, Clin-
ical Modification (ICD-9-CM) codes for CAS and CEA. The primary outcomes
were in-hospital mortality, stroke, hospital charges, and discharge disposi-
tion. Subgroup analyses were performed to evaluate these outcomes by
neurologic presentation using c2 and multivariable logistic regression.
Results: Of the 404,256 discharges for carotid revascularization, CAS utiliza-
tion was 66% higher in 2006 than in 2005 (9.3% vs 14%, P = .0004). Crude
mortality, stroke, and median charges remained higher for CAS than for
Abstracts 297CEA; discharge to home was more common after CEA. Results improved from
2005 to 2007. By logistic regression of the total cohort from 2005 to 2006,
CAS was independently predictive of mortality (odds ratio [OR], 1.47; 95%
confidence interval [CI], 1.08-2.00; P < .0001). Independent predictors of
stroke included CAS (OR, 1.43; 95% CI, 1.18-1.73; P < .0001) and symptom-
atic disease (OR, 2.4; 95% CI, 2.06-2.93;P < .0001). Among subgroups based
on neurological presentation, regression showed that CAS significantly
increased the odds of stroke in asymptomatic patients (OR, 1.6; 95% CI,
1.2-2.0; P = .0003). Among symptomatic patients, CAS increased the odds
of in-hospital death (OR, 3.0; 95% CI, 1.7-5.1, P < .0001) and trended toward
significance for stroke (OR, 1.7; 95% CI, 1.0-2.8; P = .0569).
Conclusion: Utilization of CAS has increased from the years 2005 to 2007
with some improvements in the outcome. Despite improvements in
outcome, resource utilization remains significantly higher for CAS than CEA.The incidence of microemboli to the brain is less with endarterectomy
than with percutaneous revascularization with distal filters or flow
reversal
Naren Gupta, Matthew A. Corriere, Thomas F. Dodson, Elliot L. Chaikof,
Robert J. Beaulieu, James G. Reeves, Atef A. Salam, Karthikeshwar
Kasirajan
Background: Current data suggest microembolization to the brain may
result in long-term cognitive dysfunction despite the absence of immediate
clinically obvious cerebrovascular events. We reviewed a series of patients
treated electively with carotid endarterectomy (CEA), carotid artery stent-
ing (CAS) with distal filters, and carotid stenting with flow reversal (FRS)
monitored continuously with transcranial Doppler scan (TCD) during the
procedure to detect microembolization rates.
Methods: TCD insonation of the M1 segment of the middle cerebral artery
was conducted during 42 procedures (15 CEA, 20 CAS, and 7 FRS) in 41
patients seen at an academic center. One patient had staged bilateral
CEA. Ipsilateral microembolic signals (MESs) were divided into three phases:
preprotection phase (until internal carotid artery [ICA] cross-shunted or
clamped if no shunt was used, filter deployed, or flow reversal established),
protection phase (until clamp/shunt was removed, filter removed, or ante-
grade flow re-established), and postprotection phase (after clamp/shunt
was removed, filter removed, or antegrade flow re-established). Descriptive
statistics are reported as mean  SE for continuous variables and N (%) for
categorical variables. Differences in ipsilateral emboli counts based on cere-
bral protection strategy were assessed using nonparametric methods.
Results: TCD insonation and procedural success were obtained in 33 proce-
dures (79%; 14 CEA, 14 CAS, and 5 FRS). Highest ipsilateral MESs were
observed for CAS (319.3  110.3), followed by FRS (184.2  110.5), and
CEA (15.3  22.0). Pairwise comparisons revealed significantly higher ipsilat-
eral MESs with both FRS and CAS when compared to CEA (P = .007 for FRS and
P < .001 for CAS vs CEA, respectively), whereas the difference in MESs
between FRS and CAS was not significant (P = .053). Periods of maximum
embolization were postprotection phase for CEA, protection phase for
CAS, and preprotection phase for FRS. Preprotection MESs were frequently
observed during both CAS and FRS (20.4% and 63.3% of total MESs across
all phases, respectively), and the primary difference between these two
methods seemed to be related to lower MESs during the protection phase
with FRS.
Conclusion: CEA is associated with lower rates of microembolization
compared with carotid stenting. Flow reversal may represent a procedural
modification with potential to reduce microembolization during carotid
stenting; further investigation is warranted to determine the relationship
between cerebral protection strategies and outcomes associated with
carotid stenting.Reflux in foot veins is associated with venous toe and forefoot ulceration
Paul S. van Bemmelen, Daniel Spivack, Patrick Kelly
Objective: To determine the prevalence of foot vein incompetence in
a group of patients with chronic venous insufficiency and to assess the asso-
ciation of this, with venous ulceration located on the forefoot.
Methods: A total of 20 consecutive patients (21 limbs) with active or healed
venous ulceration was prospectively studied with duplex ultrasound of thesuperficial and plantar foot veins. In these, four extremities had venous
ulceration involving the forefoot. Specifically, the superficial venous arch
near the metatarsal heads, the foot portion of the great and small saphenous
veins, the anterior arch veins on the foot dorsum, and the plantar veins were
interrogated with a 12-MHz probe.
Results: Reflux was found in 32% of pedal vein segments in CEAP C5, C6 legs,
with ulceration involving only the gaiter area (mean number of incompetent
foot segments, 1.6  1.2). Pedal reflux was present in 65% of foot vein
segments when forefoot ulceration was present (mean number of incompe-
tent foot segments, 3.3  1.3). Student t-test for the difference in the mean
number of incompetent foot vein segments was significant (P < .004).
Conclusions: Venous ulceration can affect the forefoot and toe areas and is
associated with reflux in the pedal vein segments.Iatrogenic arterial injuries of spine and orthopedic operations
Sachinder Singh Hans, Alexander D. Shepard, Pritham Reddy, Kumara Rama,
William Romano
Objective: To describe the results of contemporary management of iatro-
genic arterial injuries following spine and orthopedic operations.
Methods: Patients with major arterial injuries following spine and ortho-
pedic operations in four teaching hospitals (Henry Ford Hospital, Detroit,
Mich; Henry Ford Macomb Hospital, Clinton Township, Mich; St John Macomb
Hospital, Warren, Mich; and St John Hospital, Detroit, Mich) over the last 10
years were studied. Data were collected on a continuous basis from vascular
registries and analyzed retrospectively.
Results: Seventeen patients (8 spine, 9 orthopedic operations) had iatro-
genic arterial injuries manifest as thrombosis or laceration with bleeding,
pseudoaneurysm, or arteriovenous fistula. The majority of arterial lacera-
tions with bleeding and pseudoaneurysms were treated with open surgical
repair while the majority of thromboses and arteriovenous fistulae were
treated with endovascular techniques. Fasciotomy was necessary in three
of seven patients with arterial complications of knee and hip operations.
There was no mortality or limb loss. Significant morbidity in the form of foot
drop (1), iliac vein thrombosis (2), delayed ambulation due to hematoma and
swelling of the lower extremity (2), and ischemic myonecrosis of calf
muscles (1) occurred. Two patients launched legal action.
Conclusion: Arterial injuries following orthopedic and spine operations can
be successfully managed by both open and endovascular techniques. Signif-
icant morbidity and increased length of stay is common. Patient dissatisfac-
tion with the complication and need for ensuing treatment can have
significant medicolegal consequences.The learning curve of robot-assisted laparoscopic aortofemoral bypass
grafting for aortoiliac occlusive disease
Toma´sˇ Novotny´, Martin Dvorˇa´k, Robert Staffa
Background: Since the end of the 20th century, robot-assisted surgery has
been finding its role among other minimally invasive methods. Vascular
surgery seems to be another specialty in which the benefits of this tech-
nology can be expected. Our objective was to assess the learning curve of
robot-assisted laparoscopic aortofemoral bypass grafting for aortoiliac
occlusive disease in a group of 40 patients.
Methods: Between May 2006 and January 2010, 40 patients (32 men, 8
women), who were a median age of 58 years (range, 48-75 years), under-
went 40 robot-assisted laparoscopic aortofemoral reconstructions. Learning
curve estimations were used for anastomosis, clamping, and operative time
assessment. For conversion rate evaluation, the cumulative summation (CU-
SUM) technique was used. Statistical analysis comparing the first and second
half of our group, and unilateral-to-bilateral reconstructions were
performed.
Results: We created 21 aortofemoral and 19 aortobifemoral bypasses. The
median proximal anastomosis time was 23 minutes (range, 18-50 minutes),
median clamping time was 60 minutes (range, 40-95 minutes), and median
operative time was 295 minutes (range, 180-475 minutes). The 30-day
mortality rate was 0%, and no graft or wound infection or cardiopulmonary
or hepatorenal complications were observed. During the median 18-month
follow-up (range, 2-48 months), three early graft occlusions occurred (7%).
After reoperations, the secondary patency of reconstructions was 100%. Data
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tion with anastomosis and clamping time reduction. The operative time
learning curve was flat, confirming the procedure’s complexity. There were
two conversions to open surgery. CUSUM analysis confirmed that an accept-
able conversion rate set at 5% was achieved. Comparing the first and second
half of our group, all recorded times showed statistically significant improve-
ments. Differences between unilateral and bilateral reconstructions were
not statistically significant.
Conclusions: Our results show that the success rate of robot-assisted laparo-
scopic aortofemoral bypass grafting is high and the complication rate is low.
Anastomosis creation, one of the main difficulties of laparoscopic bypass
grafting, has been overcome using the robotic operating system and its
learning curve is short. However, the endoscopic dissection of the aortoiliac
segment remains the most difficult part of the operation and should be ad-
dressed in further development of the method to reduce the operative
times. Long-term results and potential benefits of this minimally invasive
method have to be verified by randomized controlled clinical trials.Vascular smooth muscle enhances functionality of tissue-engineered
blood vessels in vivo
Lucas P. Neff, Bryan W. Tillman, Saami K. Yazdani, Masood A. Machingal,
James J. Yoo, Shay Soker, Brian W. Bernish, Randolph L. Geary, George J.
Christ
Objectives: There is significant room for improvement in the development
of tissue-engineered blood vessels (TEBVs) for vascular reconstruction. Most
commonly, TEBVs are seeded with endothelial cells (ECs) only. This provides
an antithrombogenic surface but suboptimal physiologic characteristics
compared with native arteries, due to lack of smooth muscle cells (SMCs)
in the vessel media. Although SMCs are critical in vessel architecture and
function throughout the vascular tree, few studies have incorporated SMCs
in TEBVs implanted in vivo. As such, the goal of the present study was to
evaluate the effect of SMC coseeding with ECs on TEBV maturation, struc-
ture, and function after prolonged in vivo maturation.
Methods: Dual-seeded TEBVs (dsTEBVs) were created by coseeding autolo-
gous ECs derived from circulating progenitor cells and SMCs from arteryexplants onto the lumen and outer surface of extracellular matrix scaffolds,
respectively. Control vessels were seeded with ECs alone (ecTEBV). All
vessels were preconditioned to pulsatile flow for 10 to 14 days in a biore-
actor, implanted as arterial interposition grafts in sheep, and allowed to
heal and adapt in vivo for 4 months before ex vivo physiologic testing and
histologic analysis.
Results: All implants were patent at 4 months. There were no structural fail-
ures, aneurysms, or infectious complications. The dsTEBVs exhibited
a greater degree of wall maturation, characterized by higher medial cellu-
larity (P = .01) and greater percentage of a-actin (P = .005) and SMC-specific
muscle myosin heavy chain (P = .005) staining compared with ecTEBVs.
Contractile responses to phenylephrine and serotonin were significantly
greater in isolated rings of dsTEBVs than those observed in ecTEBVs (P = .01).
Conclusions: To our knowledge, this is the first study that demonstrates
enhanced in vivo wall maturation and contractile function of TEBVs co-
seeded with autologous SMCs and ECs compared with EC seeding alone.
These data suggest a coseeding strategy can be accomplished in a clinically
relevant timeframe (typically 6 weeks) and may provide advantages for arte-
rial reconstruction compared with vessels engineered only with
endothelium.
Clinical Relevance: Bioengineering of functional blood vessels using autol-
ogous cells has been proposed as an alternative to prosthetic grafts for
patients who lack suitable vein. Previous studies have focused on attaching
endothelial cells to the luminal wall of prosthetic or tissue-engineered
vessels. However, vascular smooth muscle cells (SMCs), which comprise
the bulk of the artery wall, are essential in regulating artery wall geometry,
tone, and integrity in response to a variety of hemodynamic and biochem-
ical stimuli. Therefore, the addition of an SMC layer to an engineered blood
vessel would enhance its function. This study evaluated the effect of incor-
porating vascular SMCs and endothelium into an engineered blood vessel
that was implanted for 4 months in vivo. All vessels remained patent and
maintained stable wall geometry without significant stenosis, dilation, or
rupture. Dual-seeded vessels demonstrated enhanced structure and func-
tion with greater numbers of cells expressing SMC markers in the medial
layer and significantly improved vasomotor responses than did vessels
seeded with endothelium alone. This strategy may soon evolve into a clini-
cally useful alternative for pat ients lacking vein for vascular
reconstructions.
